Sergio Cifuentes Canaval: Treatment Beyond ADCs Progression and ADCs Sequencing
Sergio Cifuentes Canaval, Cancer Research Project Manager at CENEIT Mexico, shared a post on LinkedIn:
” Excited for the Second Session of the SOLTI cancer research Young – Development Program!
The SOLTI Young – Development Program continues with the second session, and this time, we have the privilege of learning from Paolo Tarantino (Dana-Farber Cancer Institute) as he shares insights on:
“Treatment Beyond ADCs Progression and ADCs Sequencing”
Moderated by Pablo Tolosa (Hospital 12 de Octubre) and Elia Seguí, MD (Dana-Farber Cancer Institute), this session promises to be an engaging discussion on one of the most dynamic areas in breast cancer treatment.
With ADCs transforming therapeutic strategies, understanding how to optimize sequencing and manage progression is key to improving patient outcomes. I’m looking forward to learning, discussing, and exchanging ideas with colleagues from different backgrounds.
Grateful for these spaces that keep us growing as oncologists and Investigators!”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023